Showing results (221-230 of 229) with videos related to
Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Scientific Reports|January 3, 2025
Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapyRachael A Potter, Ida H Moeller, Sohrab Khan, et al.American Heart Journal|January 3, 2023
Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims dataRobert J Cubeddu, Shannon M E Murphy, Craig R Asher, et al.Interactive Cardiovascular and Thoracic Surgery|December 14, 2020
Joint preoperative transthoracic and intraoperative transoesophageal echocardiographic assessment of functional mitral regurgitation severity provides better association with long-term mortalityShyamal R Asher, Gregory W Malzberg, Chin Siang Ong, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2022
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trialJ S Frenel, J W Kim, N Aryal, et al.Journal of the American College of Cardiology|September 18, 2020
Impact of Transcatheter Aortic Valve Replacement on Severity of Chronic Kidney DiseaseRobert J Cubeddu, Craig R Asher, Ashley M Lowry, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|August 4, 2009
Comprehensive left atrial appendage optimization of thrombus using surface echocardiography: the CLOTS multicenter pilot trialJohn A Sallach, Sarinya Puwanant, Jeanne K Drinko, et al.Neurology and Therapy|January 10, 2026
Two-Year Outcomes Following Delandistrogene Moxeparvovec Treatment in Ambulatory Patients with Duchenne Muscular Dystrophy: Phase 3 EMBARK TrialJerry R Mendell, Francesco Muntoni, Craig M McDonald, et al.Nature Medicine|October 9, 2024
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trialJerry R Mendell, Francesco Muntoni, Craig M McDonald, et al.JACC. Cardiovascular Interventions|September 24, 2021
5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney DiseaseSantiago Garcia, Robert J Cubeddu, Rebecca T Hahn, et al.Pageof 23